The Cardiac Support Device and the Myosplint: Treating heart failure by targeting left ventricular size and shape

Annals of Thoracic Surgery

Volumn 75, Issue 6 SUPPL., 2003, Pages

  Sabbah, Hani N ^a,b  

^a HENRY FORD HEALTH SYSTEM   (United States)

^b HENRY FORD HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CONFERENCE PAPER; DOG; FEASIBILITY STUDY; HEART ASSIST DEVICE; HEART DILATATION; HEART FAILURE; HEART LEFT VENTRICLE COMPLIANCE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE SIZE; HEART LEFT VENTRICLE VOLUME; HEART PROTECTION; HEART STRESS; HEART VENTRICLE PACING; HEART VENTRICLE REMODELING; LONG TERM CARE; MICROEMBOLISM; NONHUMAN; PRIORITY JOURNAL; QUALITY OF LIFE;

ANIMALS; DOGS; HEART FAILURE, CONGESTIVE; HEART VENTRICLES; HEART-ASSIST DEVICES; HUMANS; SPLINTS; VENTRICULAR REMODELING;

EID: 0037974870     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0003-4975(03)00463-6     Document Type: Conference Paper

References (42)

1. Cohn JN, Ferrari R, Sharp N, for an International Forum on Cardiac Remodeling. Cardiac remodeling - concepts and clinical implication: a consensus paper from an international forum on cardiac remodeling. J Am Coll Cardiol 2000;35:569-82.
2. Francis GS. Pathophysiology of chronic heart failure. Am J Med 2001;110:37S-46S.
3. Sabbah HN, Goldstein S. Ventricular remodeling: consequences and therapy. Eur Heart J 1993;14:C24-C29.
4. Douglas PS, Morrow R, Ioli A, Reichek N. Left ventricular shape, afterload and survival in idiopathic dilated cardiomyopathy. J Am Coll Cardiol 1989;13:311-5.
5. White HD, Norris RM, Brown MA, et al. Left ventricular end-systolic volume as the major determinant of survival after recovery from myocardial infarction. Circulation 1987;76:44-51.
6. Vasan RS, Larson MG, Benjamin EJ, et al. Left ventricular dilatation and the risk of congestive heart failure in people without myocardial infarction. N Engl J Med 1997;336:1350-5.
7. 2+-dependent signaling. Circ Res 1995;76:1-15.
8. Yamazaki T, Komuro I, Kudoh S, et al. Angiotensin II partly mediates mechanical stress-induced cardiac hypertrophy. Circ Res 1995;77:258-65.
9. Sadoshima J, Izumo S. Mechanical stretch rapidly activates multiple signal transduction pathways in cardiac myocytes: potential involvement of an autocrine/paracrine mechanism. EMBO J 1993;12:1681-92.
10. Sadoshima J, Izumo S. Signal transduction pathways of angiotensin II induced c-fos gene expression in cardiac myocytes in vitro. Roles of phospholipid-derived second messengers. Circ Res 1993;73:424-38.
11. Sadoshima J, Jahn L, Takahashi T, et al. Molecular characterization of the stretch-induced adaptation of cultured cardiac cells. An in vitro model of load-induced cardiac hypertrophy. J Biol Chem 1992;267:10551-60.
12. Cory CR, Grange RW, Houston ME. Role of sarcoplasmic reticulum in loss of load sensitive relaxation in pressure overload hypertrophy. Am J Physiol 1994;266:H68-H78.
13. 2+-handling is an early manifestation of pressure overload hypertrophy in rat hearts. Am J Physiol 1996;271:H228-34.
14. 2+-uptake during the development of LV hypertrophy. Biochem Pharmacol 2003;65:933-9.
15. Gould KL, Lipscomb K, Hamilton GW, Kennedy JW. Relation of left ventricular shape, function and wall stress in man. Am J Cardiol 1974;34:627-34.
16. Laskey WK, St John Sutton M, Zeevi G, et al. Left ventricular mechanics in dilated cardiomyopathy. Am J Cardiol 1984;54:620-5.
17. Lamas GA, Vaughan DE, Parisi AF, Pfeffer MA. Effects of left ventricular shape and captopril therapy on exercise capacity after anterior wall acute myocardial infarction. Am J Cardiol 1989;63:1167-73.
18. Tischler MD, Niggel J, Borowski DT, LeWinter MM. Relation between left ventricular shape and exercise capacity in patients with left ventricular dysfunction. J Am Coll Cardiol 1993;22:751-7.
19. Kono T, Sabbah HN, Stein PD, Brymer JF, Khaja F. Left ventricular shape as a determinant of mitral regurgitation in patients with severe heart failure secondary to either coronary artery disease or idiopathic dilated cardiomyopathy. Am J Cardiol 1991;68:355-9.
20. Kono T, Sabbah HN, Rosman H, et al. Left ventricular shape is the primary determinant of functional mitral regurgitation in heart failure. J Am Coll Cardiol 1992;20:1594-8.
21. Sabbah HN, Rosman H, Kono T, et al. On the mechanism of functional mitral regurgitation. Am J Cardiol 1993;72:1074-6.
22. Sabbah HN, Kono T, Stein PD, Mancini GBJ, Goldstein S. Left ventricular shape changes during the course of evolving heart failure. Am J Physiol 1992;263:H266-70.
23. Goldstein S, Sabbah HN. Ventricular remodeling and angiotensin converting enzyme inhibitors. J Cardiovasc Pharmacol 1994;24:S27-31.
24. Sabbah HN, Shimoyama H, Kono T, et al. Effects of longterm monotherapy with enalapril, metoprolol and digoxin on the progression of left ventricular dysfunction and dilation in dogs with reduced ejection fraction. Circulation 1994;89:2852-9.
25. McDonald KM, Rector T, Carlyle PF, et al. Angiotensin converting enzyme inhibition and beta-adrenoceptor blockade regress established ventricular remodeling in a canine model of discrete myocardial damage. J Am Coll Cardiol 1994;24:1762-8.
26. Frazier OH, Benedict CR, Radovancevic B, et al. Improved left ventricular function after chronic left ventricular unloading. Ann Thorac Surg 1996;62:675-81.
27. Saavedra WF, Tunin RS, Paolocci N, et al. Reverse remodeling and enhanced adrenergic reserve from passive external support in experimental dilated heart failure. J Am Coll Cardiol 2002;39:2069-76.
28. Carpentier A, Chachques JC. Clinical dynamic cardiomyoplasty method and outcome. Semin Thorac Cardiovasc Surg 1991;3:136-9.
29. Moriera LF, Bocchi EA, Stolf NA, et al. Dynamic cardiomyoplasty in the treatment of dilated cardiomyopathy: current results and perspectives. J Cardiac Surg 1996;11:207-13.
30. Kass DA, Baughman KL, Pak PH, et al. Reverse remodeling from cardiomyoplasty in human heart failure: external constraint versus active assist. Circulation 1995;91:2314-8.
31. Patel HJ, Polidori DJ, Pilla JJ, et al. Stabilization of chronic remodeling by asynchronous cardiomyoplasty in dilated cardiomyopathy: effects of a conditioned muscle wrap. Circulation 1997;96:3665-71.
32. Chaudhry PA, Mishima T, Sharov VG, et al. Passive mechanical containment prevents ventricular remodeling in heart failure. Ann Thorac Surg 2000;70:1275-80.
33. Chaudhry PA, Anagnostopoulos PV, Mishima T. Acute ventricular reduction with the Acorn cardiac support device: effect on progressive left ventricular dysfunction and dilation in dogs with chronic heart failure. J Card Surg 2001;16:118-26.
34. Power JM, Raman J, Dornom A, et al. Passive ventricular constraint amends the course of heart failure: a study in an ovine model of dilated cardiomyopathy. Cardiovasc Res 1999;44:549-55.
35. Sabbah HN, Stein PD, Kono T, et al. A canine model of chronic heart failure produced by multiple sequential coronary microembolizations. Am J Physiol 1991;260:H1379-84.
36. Sabbah HN, Chaudhry PA, Kleber F, Konertz W. Passive mechanical containment of progressive left ventricular dilation: a surgical approach to the treatment of heart failure [Abstract]. J Heart Failure 2000;6:115.
37. Sabbah HN, Gupta RC, Sharov VG, et al. Prevention of progressive left ventricular dilation with the Acorn Cardiac Support Device downregulates stretch response proteins and improves sarcoplasmic reticulum calcium cycling in dogs with chronic heart failure [Abstract]. J Am Coll Cardiol 2001;37:474A.
38. Oz MC, Konertz WF, Kleber FX, et al. Global surgical experience with the Acorn cardiac support device. J Thorac Cardiovasc Surg. In press.
39. Konertz W, Kleber FX, Rombeck B, et al. Safety results and initial efficacy trends with the Acorn Cardiac Support Device in patients with advanced heart failure [Abstract]. Eur Heart J 2000;21:533.
40. Mueller XM, Tevaearai H, Boone Y, Augstburger M, von Segesser LK. An alternative to left ventricular reduction. J Heart Lung Transplant 2002;21:791-6.
41. McCarthy PM, Takagaki M, Ochiai Y, et al. Device-based change in left ventricular shape: a new concept for the treatment of dilated cardiomyopathy. J Thorac Cardiovasc Surg 2001;122:482-90.
42. Schenk S, Reichenspurner H, Boehm DH, et al. Myosplint implant and shape-change procedure: intra- and perioperative safety and feasibility. J Heart Lung Transplant 2002;21:680-6.